About Macrodeep
New report 2026 AI SDR market benchmark: six platforms, eight workflow stages See the results →

Il rapporto

Notizie verificate su finanziamenti, sedi centrali e leadership delle aziende più innovative al mondo

196 report e oltre

Aggiornato quotidianamente con le ultime intelligence di mercato
Fundraising
Mineralys Therapeutics

Mineralys Therapeutics Raises $287.5M in Public Offering

Mineralys Therapeutics, a HealthTech company based in San Francisco, CA, has raised $287.5M in Public Offering led by Public Markets.

Fundraising News Team
Sep 9, 2025
0 min read
HealthTech
Mineralys Therapeutics

Mineralys Therapeutics raises $287.5M Public Offering

Mineralys Therapeutics raises $287.5M in Public Offering. Clinical-stage biopharma developing lorundrostat for hypertension treatment...

Editorial Team
Sep 9, 2025
0 min read•$287.5M
HealthTech
Arnatar Therapeutics

Arnatar Therapeutics raises $52M Series A

Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...

Editorial Team
Aug 25, 2025
0 min read•$52M
Biotech
Denali Therapeutics

Denali Therapeutics raises $217M Series C at $5B valuation

Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...

Editorial Team
Mar 6, 2024
0 min read•$217M
HealthTech
Strand Therapeutics

Strand Therapeutics raises $153M Series B

Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...

Editorial Team
Sep 17, 2025
0 min read•$153M
Biotech
Seres Therapeutics

Seres Therapeutics raises $113M Series E at $450M valuation

Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...

Editorial Team
Jan 19, 2024
0 min read•$113M
Biotech
Crystalys Therapeutics

Crystalys Therapeutics raises $205M Series B at $900M valuation

Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...

Editorial Team
Oct 1, 2025
0 min read•$205M
Biotech
Kailera Therapeutics

Kailera Therapeutics raises $400M Series A at $1.5B valuation

Kailera Therapeutics raises $400M in Series A at $1.5B valuation. Developing obesity therapeutics with acquired pipeline...

Editorial Team
Oct 1, 2024
0 min read•$400M
Biotech
Expedition Therapeutics

Expedition Therapeutics raises $165M Series B at $850M valuation

Expedition Therapeutics raises $165M in Series B at $850M valuation. Developing novel therapeutics for cardiometabolic diseases...

Editorial Team
Jan 15, 2025
0 min read•$165M
Pagina 1

Visualizzazione di 9 report • Pagina 1 • Categoria: all

Rimani avanti rispetto al mercato

Ricevi insight settimanali nella tua casella di posta. Niente spam, solo intelligenza.